Business

NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System

Patient Treated with OneRF® Ablation System Previously Experienced up to 10 Seizures a Day EDEN PRAIRIE, Minn., June 23, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced that Clara—an early patient treated with the Company’s patented OneRF® Ablation System—has successfully surpassed the o

articleNeuroone Medical Technologies CorporationJune 23, 20255/company/neuroone-medical-technologies-corp/news/neuroone-patient-surpasses-one-milestone-123000669
NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System

About this update from Neuroone Medical Technologies Corporation

[{"type":"image","alt":"NeuroOne Medical Technologies Corporation","displaySize":"","headline":null,"caption":"NeuroOne Medical Technologies Corporation","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":48,"url":"https://media.zenfs.com/en/globenewswire.com/819fe13d4f4c15d1a815f2aae4dd578b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/pp0tg2T4IB9hXCYxVLu0sA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTY3O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/819fe13d4f4c15d1a815f2aae4dd578b","width":300,"height":48}},"lazy":false},{"type":"text","content":"Patient Treated with OneRF® Ablation System Previously Experienced up to 10 Seizures a Day","length":90,"tagName":"p"},{"type":"text","content":"EDEN PRAIRIE, Minn., June 23, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced that Clara—an early patient treated with the Company’s patented OneRF® Ablation System—has successfully surpassed the one year milestone of being seizure free.","length":469,"tagName":"p"},{"type":"text","content":"Clara was one of the first patients to undergo treatment using NeuroOne’s OneRF® platform. Since the procedure in June 2024, Clara has been completely seizure-free, which has greatly improved her quality of life.","length":212,"tagName":"p"},{"type":"text","content":"Videos of Clara’s journey can be found on the company’s website, as well as features on Fox News and Good Morning America.","length":122,"tagName":"p"},{"type":"text","content":"The OneRF® Ablation System is the first and only FDA 510(k)-cleared device that uses the same sEEG electrode for both diagnostic and therapeutic applications. It not only provides monitoring, mapping and ablation, but also provides the ability to perform the ablation at the patient’s bedside. To date, the technology has demonstrated seizure reduction or seizure freedom for most patients that have received an ablation with the OneRF System.","length":443,"tagName":"p"},{"type":"text","content":"“This milestone further validates the intended benefits of our OneRF® platform,” said Dave Rosa, CEO of NeuroOne. “Our next step is to leverage the technology for other applications, ...

More updates from Neuroone Medical Technologies Corporation

NeuroOne Medical Technologies CorporationThe Companyneurological disordersClara